李辉,夏博,米秀青,郑耐心,艾虎,唐国栋,张慧平,杨国建,赵迎,孙福成

• 1:北京医院心内科国家老年医学中心中国医学科学院老年医学研究院
• 2:冠县人民医院心内科

摘要(Abstract)：

目的评估准分子激光消蚀术在支架内再狭窄病变治疗中的疗效和安全性。方法回顾性分析从2017年12月至2018年12月在北京医院应用准分子激光消蚀术治疗的支架内再狭窄患者共11例,其中4例(4/11)为慢性完全闭塞病变。11例患者根据参考血管直径、血管狭窄程度选择不同直径的激光导管消蚀病变,后续采用球囊扩张、药物洗脱球囊和(或)药物洗脱支架完成最终治疗。应用定量冠状动脉造影在激光治疗前、激光治疗后及最终影像结果进行最小管腔直径的测量,所有的患者住院期间监测治疗效果,并进行了术后9个月的临床电话随访。结果 11例患者均取得了即刻手术成功,激光治疗后最小管腔直径较治疗前增加[1.37(1.00,2.40)mm比0.76(0.10,2.31)mm,P<0.05]。所有患者术中未发生急性血管闭塞、血管夹层。有2例(2/11)患者出现了EllisⅡ型冠状动脉穿孔,未采取任何特殊处理且病情稳定。住院期间无死亡及靶病变血运重建发生。9个月随访时所有患者无死亡、心肌梗死发生,但是仍有2例(2/11)患者进行了靶病变血运重建治疗。结论准分子激光消蚀术对于复杂的支架内再狭窄病变是一项安全有效的治疗措施。单纯准分子激光消蚀治疗可以明显增加残余管腔直径,可取得满意的术后即刻及9个月治疗效果。

关键词(KeyWords)： 准分子激光消蚀术;支架内再狭窄

Abstract:

Keywords:

基金项目(Foundation): 2017年首都特色临床特色应用研究与成果推广项目（Z71100001017202）

作者(Author): 李辉,夏博,米秀青,郑耐心,艾虎,唐国栋,张慧平,杨国建,赵迎,孙福成

参考文献(References)：

• [1]胡盛寿，高润霖，刘力生，等.《中国心血管病报告2018》概要.中国循环杂志，2019,34(3):209-220.
• [2] B?naa KH, Mannsverk J, Wiseth R, et al. Drug-eluting or baremetal stents for coronary artery disease. N Engl J Med,2016,375(13):1242-1252.
• [3] Shlofmitz E, Iantorno M, Waksman R. Restenosis of drug-eluting stents:A new classification system based on disease mechanism to guide treatment and state-of-the-art review. Circ Cardiovasc Interv,2019, 12(8):007023.
• [4] Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention:A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol,2011, 58(24):e44-e122.
• [5] Rawlins J, Din JN, Talwar S, et al. Coronary Intervention with the excimer laser:Review of the technology and outcome data. Interv Cardiol, 2016, 11(1):27-32.
• [6] Thygesen K, Alpert JS, Jaff e AS, et al. Forth universal definition of myocardial infarction. J Am Coll Cardiol, 2018, 72(18):2231-2264.
• [7]董蓉，郑道生，包世宏，等.准分子激光对不同成分粥样斑块的消蚀效应.中国激光医学杂志，1993, 2(1):12-15.
• [8]徐英恺，李拥军.准分子激光在冠状动脉介入治疗中的应用进展.国际心血管病杂志，2018,45(4):196-199.
• [9]夏俊刚，陈庭仁.激光血管成形术的研究进展.神经损伤与功能重建，1991,1(2):49-55.
• [10] Burris N, Lippincott RA, Elfe A, et al. Eff ects of 308 nanometer excimer laser energy on 316L stainless-steel stents:implications for laser atherectomy of in-stent restenosis. J Invasive Cardiol, 2000, 12(11):555-559.
• [11] Mehran R, Mintz GS, Satler LF, et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty:mechanisms and results compared with PTCA alone. Circulation, 1997, 96(7):2183-2189.
• [12] Lam SCC, Bertog S, Sievert H. Excimer laser in management of underexpansion of a newly deployed coronary stent. Catheter Cardio Inte, 2014, 83(1):E64-E68.
• [13] Karacsonyi J, Armstrong EJ, Truong HTD, et al. Contemporary use of laser during percutaneous coronary interventions:Insights from the laser veterans affairs(LAVA)multicenter registry. J Invasive Cardiol, 2018, 30(6):195-201.
• [14]李琪，刘健，卢明瑜，等.准分子激光冠状动脉斑块消融术治疗复杂冠状动脉病变的近期临床效果观察.中国介入心脏病学杂志，2019, 27(1):41-44.
• [15] Fernandez JP, Hobson AR, Mckenzie D, et al. Beyond the balloon:excimer coronary laser atherectomy used alone or in combination with rotational atherectomy in the treatment of chronic total occlusions, non-crossable and non-expansible coronary lesions.Euro Intervention, 2013, 9(2):243-250.